Skip to main content

Headlines

More screen time is linked to poorer child development, study shows
posted:
by: CNN Most Recent
#channels:: #All, #World, #Latest, #News, #CNN
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AI chatbots linked to higher loneliness in middle-schoolers, study warns
posted:
by: Fox Video
#channels:: #All, #News, #Fox, #Video, #FoxVideo
AI chatbots linked to higher loneliness in middle-schoolers, study warns
posted:
by: Fox Video
#channels:: #All, #News, #Fox, #Video, #FoxVideo
Oncolytics Nears Interim Data Update From Randomized REO 033 Colorectal Cancer Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Mirum's Brelovitug Meets Phase 3 Goals In Chronic Hepatitis Delta Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
OSE Immunotherapeutics Highlights Pipeline Progress As Phase 3 Tedopi Study Advances
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Innovent Expands Phase 3 IBI363 Study To Non-Squamous Lung Cancer; Stock Down
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Mirum To Announce Topline Results From Phase 3 AZURE-1 Study For Brelovitug
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AC Immune Parkinson’s Vaccine Study Meets Safety, Immunogenicity Goals
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
New study reveals the estate-planning choices that are likely to pit heirs against each other
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
One of history's most famous sayings about Rome may be wrong, new study suggests
posted:
by: Fox Travel
#channels:: #All, #News, #Travel, #Fox, #FoxTravel